3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Reserpine: new trials by email Literature Review of Reserpine trials Research Report on Reserpine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanisms of Refractory Hypertension (Reserpine) Reserpine - Refractory Hypertension | Phase 2 | Completed | University of Alabama at Birmingham | 7 | 2015-07-23 | 2021-11-30 |
| Reserpine for the Treatment of Cocaine Dependence - 1 Reserpine - Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 140 | 2001-07-01 | 2017-01-12 |
| Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) chlorthalidone, reserpine, hydralazine - Cardiovascular Diseases, Heart Diseases | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1980-09-01 | 2013-11-26 |
Hypertension (2) · Cardiovascular Diseases (1) · Cocaine-Related Disorders (1) · Heart Diseases (1) · Substance-Related Disorders (1) · Vascular Diseases (1)
National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute on Drug Abuse (NIDA) (1) · University of Alabama at Birmingham (1)
United States (2)
David A Calhoun, MD (1) · Eugene Somoza, M.D., Ph.D. (1) · H. Perry (1) · Harold Schnaper (1) · James Schoenberger (1) · Merwyn Greenlick (1) · Robert McDonald (1)